The emergence of genomics and proteomics as twin pillars of molecular medicine has fundamentally transformed the delivery of healthcare from a population-based model to an individualized one. This article examines the technical underpinnings of genomic sequencing and proteomic technologies, their integration into clinical workflows, and their measurable impact on diagnostic precision, biomarker discovery, and therapeutic outcomes. Drawing on current evidence, we evaluate specific clinical applications across oncology, cardiology, pharmacogenomics, and neurology, and present comparative data on biomarker accuracy and treatment effectiveness. We also address emerging challenges including data governance, computational infrastructure, and equitable access. The article concludes with a prospective assessment of artificial intelligence-driven multi-omics integration as the foundation of next-generation precision medicine.